Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer

Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer

Ubiquitin-specific protease 22 (USP22), a novel ubiquitin hydrolase, has been implicated in oncogenesis and cancer progression in various types of human cancer. However, the clinical significance of USP22 expression in non-small cell lung cancer (NSCLC) has not been determined. In the present study,...

Full description

Bibliographic Details
Main Authors: J. Ning, J. Zhang, W. Liu, Y. Lang, Y. Xue, S. Xu
Format: Article
Language:English
Published: PAGEPress Publications 2012-11-01
Series:European Journal of Histochemistry
Subjects:
Ubiquitin-specific protease 22, nonsmall cell lung cancer, prognosis.
Online Access:http://www.ejh.it/index.php/ejh/article/view/2067

Internet

http://www.ejh.it/index.php/ejh/article/view/2067

Similar Items